VNDA short interest
Vanda Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 7,831,971 |
|---|---|
| Change vs prior report | -663,319 (-7.8%) |
| Change over six months | +47.5% |
| Days to cover | 6.45 (sector: 3.78) |
| Average daily volume | 1,213,899 |
| Rank in Healthcare | #285 of 922 by days to cover |
VNDA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 7,831,971 | -7.8% | 6.45 | 1,213,899 |
| 2026-09-15 | 8,495,290 | +10.5% | 12.07 | 703,578 |
| 2026-08-31 | 7,686,226 | +0.2% | 9.87 | 778,741 |
| 2026-08-14 | 7,668,642 | +3.3% | 6.16 | 1,245,730 |
| 2026-07-31 | 7,422,856 | +3.3% | 9.00 | 824,875 |
| 2026-07-15 | 7,188,123 | -2.1% | 8.80 | 816,704 |
| 2026-06-30 | 7,342,818 | +5.1% | 7.87 | 932,697 |
| 2026-06-15 | 6,989,104 | +2.6% | 7.78 | 898,460 |
| 2026-05-29 | 6,811,524 | +7.0% | 6.80 | 1,001,794 |
| 2026-05-15 | 6,368,418 | +2.8% | 4.90 | 1,299,942 |
| 2026-04-30 | 6,196,446 | +10.7% | 5.76 | 1,076,550 |
| 2026-04-15 | 5,597,992 | +5.4% | 5.45 | 1,026,757 |
| 2026-03-31 | 5,310,265 | +65.9% | 2.39 | 2,225,454 |
| 2026-03-13 | 3,200,424 | -26.4% | 1.69 | 1,888,950 |
| 2026-02-27 | 4,346,005 | +25.3% | 1.00 | 6,341,392 |
| 2026-02-13 | 3,469,008 | +7.6% | 2.69 | 1,288,597 |
| 2026-01-30 | 3,224,168 | +12.0% | 4.07 | 792,102 |
| 2026-01-15 | 2,879,747 | +23.3% | 1.41 | 2,042,973 |
| 2025-12-31 | 2,335,804 | -52.3% | 1.00 | 3,604,016 |
| 2025-12-15 | 4,892,408 | +5.4% | 3.26 | 1,501,437 |
| 2025-11-28 | 4,642,254 | +19.6% | 3.60 | 1,290,434 |
| 2025-11-14 | 3,882,165 | -2.5% | 7.18 | 540,480 |
| 2025-10-31 | 3,983,691 | +4.2% | 5.34 | 745,403 |
| 2025-10-15 | 3,824,568 | +4.3% | 6.51 | 587,864 |
| 2025-09-30 | 3,665,733 | -20.4% | 7.57 | 484,435 |
import finzdata as yf
yf.Ticker("VNDA").short_interest # every report since 2017
yf.Client().short_interest(["VNDA"], start="2018-01-01")Healthcare short interest · VNDA price history · Who owns VNDA · All short interest